150 related articles for article (PubMed ID: 9585065)
1. Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line.
Mealey KL; Barhoumi R; Rogers K; Kochevar DT
Cancer Lett; 1998 Apr; 126(2):187-92. PubMed ID: 9585065
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
3. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
6. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.
Stein U; Walther W; Shoemaker RH
Br J Cancer; 1996 Nov; 74(9):1384-91. PubMed ID: 8912533
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.
Kanzaki A; Takebayashi Y; Ren XQ; Miyashita H; Mori S; Akiyama S; Pommier Y
Mol Cancer Ther; 2002 Dec; 1(14):1327-34. PubMed ID: 12516966
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
Cagliero E; Ferracini R; Morello E; Scotlandi K; Manara MC; Buracco P; Comandone A; Baroetto Parisi R; Baldini N
Oncol Rep; 2004 Nov; 12(5):1023-31. PubMed ID: 15492788
[TBL] [Abstract][Full Text] [Related]
9. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Roundhill EA; Jabri S; Burchill SA
Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
[TBL] [Abstract][Full Text] [Related]
10. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
[TBL] [Abstract][Full Text] [Related]
11. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
12. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
13. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.
Daly C; Coyle S; McBride S; O'Driscoll L; Daly N; Scanlon K; Clynes M
Cytotechnology; 1996; 19(3):199-205. PubMed ID: 8862007
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
15. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
Shnyder SD; Hayes AJ; Pringle J; Archer CW
Br J Cancer; 1998 Sep; 78(6):757-9. PubMed ID: 9743295
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells.
Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N
Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia.
Lopes EC; Ernst G; Aulicino P; Vanzulli S; García M; Alvarez E; Hajos SE
Clin Exp Metastasis; 2002; 19(4):283-90. PubMed ID: 12090468
[TBL] [Abstract][Full Text] [Related]
20. The Influence of MDR1 Expression Regulated by miR-138 through TRPS1 Signaling Pathway on Multidrug Resistance of Osteosarcoma and Formation of Bacterial Infection Biofilm.
Fang X; Zhu L; Wu Q; Zhong X; Chen Y; Zhu W
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):51-57. PubMed ID: 37571901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
